US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mural Oncology

2.69

-0.0100-0.37%

Pre-market: 2.60-0.0900-3.35%07:24 EDT

Volume:1.38M

Turnover:3.65M

Market Cap:46.34M

PE:-0.35

High:2.79

Open:2.60

Low:2.55

Close:2.70

Loading ...

Overview Company News Filings

BRIEF-Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown In Its Artistry-1 Clinical Trial Of Nemvaleukin

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in Its Artistry-1 Clinical Trial of Nemvaleukin, Its Lead Engineered Fusion Protein, in the Journal for Immunotherapy of Cancer

THOMSON REUTERS

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer

Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX), Mural Oncology Plc (MURA) and Copa Holdings (CPA)

Mural Oncology files $300M mixed securities shelf

Mural Oncology Plc Files for Mixed Shelf Offering of up to $300 Mln- SEC Filing

THOMSON REUTERS

BRIEF-Mural Oncology Announces Q3 2024 Financial Results And Provides Update On Pipeline Progress

Mural Oncology Q3 2024 GAAP EPS $(1.87) Beats $(1.98) Estimate, Cash, Cash Equivalents, And Marketable Securities Of $175.5M Are Expected To Fund Its Operations Into The Fourth Quarter Of 2025

Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress

THOMSON REUTERS

Mural Oncology Plc: Reiterates Guidance on Projected Cash Runway Into Q4 2025

THOMSON REUTERS

Mural Oncology Plc: Qtrly Shr Loss $1.87

THOMSON REUTERS

Calendar of U.S. Earnings Expected in the Week Ahead

Mural Oncology to Participate in Two Upcoming Investor Conferences

Mural Oncology Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MURA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MURA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MURA\",,,,,undefined,":{"symbol":"MURA","market":"US","secType":"STK","nameCN":"Mural Oncology","latestPrice":2.69,"timestamp":1745265600000,"preClose":2.7,"halted":0,"volume":1375890,"hourTrading":{"tag":"盘前","latestPrice":2.6,"preClose":2.69,"latestTime":"07:24 EDT","volume":2679,"amount":6997.8003618,"timestamp":1745321054093},"delay":0,"floatShares":11823307,"shares":17228291,"eps":-7.5799,"marketStatus":"Pre-Mkt","change":-0.01,"latestTime":"04-22 07:27:19 EDT","open":2.6,"high":2.79,"low":2.55,"amount":3648119.500824,"amplitude":0.088889,"askPrice":2.63,"askSize":1,"bidPrice":2.6,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-7.5799,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":2.69,"preHourTrading":{"tag":"盘前","latestPrice":2.6,"preClose":2.69,"latestTime":"07:24 EDT","volume":2679,"amount":6997.8003618,"timestamp":1745321054093},"postHourTrading":{"tag":"盘后","latestPrice":2.61,"preClose":2.69,"latestTime":"19:59 EDT","volume":16787,"amount":44499.6456,"timestamp":1745279979616},"volumeRatio":0.025094659113626103,"impliedVol":0.689,"impliedVolPercentile":0.2747},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MURA\",,,,,undefined,":{"symbol":"MURA","floatShares":11823307,"roa":"-36.68%","roe":"-63.57%","lyrEps":-7.5799,"volumeRatio":0.025094659113626103,"shares":17228291,"dividePrice":0,"high":2.79,"amplitude":0.088889,"preClose":2.7,"low":2.55,"week52Low":0.95,"pbRate":"0.33","week52High":4.74,"institutionHeld":0,"latestPrice":2.69,"committee":0.996008,"eps":-7.5799,"divideRate":0,"volume":1375890,"delay":0,"ttmEps":-7.5799,"open":2.6,"prevYearClose":3.22,"prevWeekClose":2.7,"prevMonthClose":1.26,"prevQuarterClose":1.26,"fiveDayClose":1.03,"twentyDayClose":3.85,"sixtyDayClose":3.92},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MURA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2485174981","title":"BRIEF-Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown In Its Artistry-1 Clinical Trial Of Nemvaleukin","url":"https://stock-news.laohu8.com/highlight/detail?id=2485174981","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485174981?lang=en_us&edition=fundamental","pubTime":"2024-11-21 06:21","pubTimestamp":1732141317,"startTime":"0","endTime":"0","summary":"BRIEF-Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown In Its Artistry-1 Clinical Trial Of NemvaleukinNov 20 (Reuters) - Mural Oncology PLC MURA.O:MURAL ON","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUABR6QBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MURA"],"gpt_icon":1},{"id":"2485173747","title":"Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in Its Artistry-1 Clinical Trial of Nemvaleukin, Its Lead Engineered Fusion Protein, in the Journal for Immunotherapy of Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2485173747","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485173747?lang=en_us&edition=fundamental","pubTime":"2024-11-21 05:15","pubTimestamp":1732137300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUABR6QBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2485337175","title":"Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2485337175","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485337175?lang=en_us&edition=fundamental","pubTime":"2024-11-21 05:15","pubTimestamp":1732137300,"startTime":"0","endTime":"0","summary":"Nemvaleukin was generally well tolerated in ARTISTRY-1, a completed phase 1/2 clinical trial, with durable responses observed in both monotherapy and combination therapy across a range of heavily pret","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/20/2984774/0/en/Mural-Oncology-Announces-Publication-Highlighting-Promising-Clinical-Antitumor-Activity-Shown-in-its-ARTISTRY-1-Clinical-Trial-of-Nemvaleukin-its-Lead-Engineered-Fusion-Protein-in-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","BK4107","L","PROC","BK4585","LU0053666078.USD","MURA","BK4588"],"gpt_icon":0},{"id":"2483761518","title":"Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX), Mural Oncology Plc (MURA) and Copa Holdings (CPA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483761518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483761518?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:00","pubTimestamp":1731585656,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 3 analysts just weighed in on Kyverna Therapeutics, Inc. (KYTX – Research Report), Mural O...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-kyverna-therapeutics-inc-kytx-mural-oncology-plc-mura-and-copa-holdings-cpa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-kyverna-therapeutics-inc-kytx-mural-oncology-plc-mura-and-copa-holdings-cpa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4141","CPA","BK4139","NA","KYTX","BK4008","BK4500","MURA"],"gpt_icon":0},{"id":"2483638158","title":"Mural Oncology files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2483638158","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483638158?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:10","pubTimestamp":1731532251,"startTime":"0","endTime":"0","summary":"16:08 EST Mural Oncology (MURA) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mural-oncology-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mural-oncology-files-300m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2483686678","title":"Mural Oncology Plc Files for Mixed Shelf Offering of up to $300 Mln- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2483686678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483686678?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:08","pubTimestamp":1731532122,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nFWN3MK2F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2483007539","title":"BRIEF-Mural Oncology Announces Q3 2024 Financial Results And Provides Update On Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2483007539","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483007539?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:11","pubTimestamp":1731503513,"startTime":"0","endTime":"0","summary":"Nov 13  - Mural Oncology PLC   :   * MURAL ONCOLOGY ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES UPDATE ON PIPELINE PROGRESS   * MURAL ONCOLOGY PLC: REITERATES GUIDANCE ON PROJECTED CASH RUNWAY INTO Q4 2025   * MURAL ONCOLOGY PLC: QTRLY LOSS PER SHARE $1.87Source text:   Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0724618433.USD","LU1720051108.HKD","LU1861215975.USD","LU0348723411.USD","LU0124384867.USD","LU1861220033.SGD","BK4139","BK4141","IE00BZ199S13.USD","LU1978683503.SGD","BK4512","LU1548497426.USD","LU1861219969.SGD","BK4585","BK4588","LU2357305700.SGD","LU1720051017.SGD","BK4097","LU2360107325.USD","IE00BD6J9T35.USD","MURA","PRGS","LU1861214812.USD","LU2065732104.USD","LU1854104046.USD","LU1854103824.USD","LU2298322129.HKD"],"gpt_icon":0},{"id":"2483062090","title":"Mural Oncology Q3 2024 GAAP EPS $(1.87) Beats $(1.98) Estimate, Cash, Cash Equivalents, And Marketable Securities Of $175.5M Are Expected To Fund Its Operations Into The Fourth Quarter Of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2483062090","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483062090?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:12","pubTimestamp":1731499967,"startTime":"0","endTime":"0","summary":"Mural Oncology (NASDAQ:MURA) reported quarterly losses of $(1.87) per share which beat the analyst consensus estimate of $(1.98) by 5.56 percent. This is a 39.09 percent increase over losses of $(3.07) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41935172/mural-oncology-q3-2024-gaap-eps-1-87-beats-1-98-estimate-cash-cash-equivalents-and-marketable-secur","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Mural Oncology Q3 2024 GAAP EPS $(1.87) Beats $(1.98) Estimate, Cash, Cash Equivalents, And Marketable Securities Of $175.5M Are Expected To Fund Its Operations Into The Fourth Quarter Of 2025","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MURA"],"gpt_icon":0},{"id":"2483983005","title":"Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2483983005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483983005?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:00","pubTimestamp":1731499204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUABRHSYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2483006806","title":"Mural Oncology Plc: Reiterates Guidance on Projected Cash Runway Into Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2483006806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483006806?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:00","pubTimestamp":1731499204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUABRHSYG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2483006804","title":"Mural Oncology Plc: Qtrly Shr Loss $1.87","url":"https://stock-news.laohu8.com/highlight/detail?id=2483006804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483006804?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:00","pubTimestamp":1731499204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUABRHSYG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2483488077","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2483488077","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483488077?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:00","pubTimestamp":1731495600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GAMB","ADAP","INKT","KRMD","ICAD","BLRX","CELC","GOEV","INO","AFCG","BRAG","DNMR","KORE","CREX","MCRB","DMAC","AMAT","MIST","BEEM","MURA","EXAI","BN","UGP","LVLU","SONO","BZH","SLRN","ASND","IVVD","INVZ","ENLT","CIG","DGII","DTI","HAYN","HI","LQDA","SLE","GLOB","HBM","BRFS","CINT","JD","CPRT","BOXL","SHCO","KMDA","DFLI","EC"],"gpt_icon":1},{"id":"2482009882","title":"Mural Oncology to Participate in Two Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2482009882","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482009882?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:00","pubTimestamp":1731326400,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass. and DUBLIN, Nov.  11, 2024  (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/11/2978181/0/en/Mural-Oncology-to-Participate-in-Two-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2482207880","title":"Mural Oncology Price Target Maintained With a $18.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2482207880","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482207880?lang=en_us&edition=fundamental","pubTime":"2024-11-11 19:37","pubTimestamp":1731325020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MURA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2024 06:37 ET (11:37 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MURA"],"gpt_icon":0},{"id":"2481915088","title":"Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481915088","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481915088?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:15","pubTimestamp":1731014100,"startTime":"0","endTime":"0","summary":"Less frequent IV dosing with nemvaleukin in patients with select advanced solid tumors, including ovarian cancer and mucosal melanoma, showed tumor site-specific pharmacodynamic activity and immune ac","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/07/2977227/0/en/Mural-Oncology-Presents-Clinical-and-Preclinical-Data-Across-its-Pipeline-at-the-39th-Annual-Meeting-of-the-Society-for-Immunotherapy-of-Cancer-SITC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011746.SGD","BK1103","BK1541","MURA","SITC","BK4231","IE00BYQNZ168.SGD","IE00BYTNYN87.SGD","BK4080","IE00B12V2V27.USD","01308","BK4139"],"gpt_icon":0},{"id":"2481597552","title":"Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481597552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481597552?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:15","pubTimestamp":1730754900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUA2XV4KX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2210150020.SGD","BK4585","IE00BKPKM429.USD","LU2095319765.USD","LU2210149790.SGD","BK4588","BK4112","IE00BGHQF748.EUR","MURA","NDAQ","IE00B3QW5Z07.USD","BK4139","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2481520465","title":"Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481520465","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481520465?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:15","pubTimestamp":1730754900,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass and DUBLIN, Nov.  04, 2024  (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapie","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/04/2974464/0/en/Mural-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","NDAQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","BK4588","BK4139",".IXIC","MURA","IE00BGHQF748.EUR","LU2210150020.SGD","BK4585","BK4112"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":57,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MURA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MURA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MURA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1743134400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MURA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MURA","date":"2025-04-21","current":-0.361956,"percent":0.455738,"low":-0.567064,"twenty":-0.422077,"median":-0.354682,"eighty":-0.301829,"high":-0.133414,"avg":-0.358674,"sd":0.07669,"marketCap":46516385},"quantilePoints":[{"date":"2024-01-05","current":-0.481599,"twenty":-0.478881,"median":-0.474804,"eighty":-0.470727,"marketCap":94630786},{"date":"2024-01-12","current":-0.410251,"twenty":-0.486355,"median":-0.471406,"eighty":-0.445585,"marketCap":80611410},{"date":"2024-01-19","current":-0.3423,"twenty":-0.481599,"median":-0.439979,"eighty":-0.393263,"marketCap":67259623},{"date":"2024-01-26","current":-0.394962,"twenty":-0.471406,"median":-0.400483,"eighty":-0.374577,"marketCap":77607258},{"date":"2024-02-02","current":-0.377974,"twenty":-0.468009,"median":-0.394962,"eighty":-0.374577,"marketCap":74269311},{"date":"2024-02-09","current":-0.361836,"twenty":-0.439979,"median":-0.387742,"eighty":-0.372878,"marketCap":71098262},{"date":"2024-02-16","current":-0.422992,"twenty":-0.422992,"median":-0.393263,"eighty":-0.372878,"marketCap":83114870},{"date":"2024-02-23","current":-0.394962,"twenty":-0.419594,"median":-0.394962,"eighty":-0.374237,"marketCap":77607258},{"date":"2024-03-01","current":-0.449322,"twenty":-0.440489,"median":-0.397934,"eighty":-0.375256,"marketCap":88288687},{"date":"2024-03-08","current":-0.463762,"twenty":-0.455438,"median":-0.398359,"eighty":-0.376785,"marketCap":91125942},{"date":"2024-03-15","current":-0.409401,"twenty":-0.455438,"median":-0.402181,"eighty":-0.377804,"marketCap":80444513},{"date":"2024-03-22","current":-0.371179,"twenty":-0.454589,"median":-0.401757,"eighty":-0.376785,"marketCap":72934133},{"date":"2024-03-28","current":-0.403798,"twenty":-0.451361,"median":-0.400058,"eighty":-0.375086,"marketCap":83766622},{"date":"2024-04-05","current":-0.375246,"twenty":-0.449322,"median":-0.398359,"eighty":-0.374978,"marketCap":77843730},{"date":"2024-04-12","current":-0.350774,"twenty":-0.445245,"median":-0.39751,"eighty":-0.372198,"marketCap":72766965},{"date":"2024-04-19","current":-0.291224,"twenty":-0.441508,"median":-0.394962,"eighty":-0.366932,"marketCap":60413503},{"date":"2024-04-26","current":-0.287961,"twenty":-0.440319,"median":-0.393263,"eighty":-0.354313,"marketCap":59736601},{"date":"2024-05-03","current":-0.311618,"twenty":-0.439979,"median":-0.38392,"eighty":-0.342979,"marketCap":64644141},{"date":"2024-05-10","current":-0.309986,"twenty":-0.43845,"median":-0.382221,"eighty":-0.327769,"marketCap":64305690},{"date":"2024-05-17","current":-0.343069,"twenty":-0.428768,"median":-0.378823,"eighty":-0.318307,"marketCap":65833885},{"date":"2024-05-24","current":-0.316611,"twenty":-0.420444,"median":-0.375426,"eighty":-0.318307,"marketCap":60756722},{"date":"2024-05-31","current":-0.295445,"twenty":-0.417386,"median":-0.374577,"eighty":-0.316082,"marketCap":56694991},{"date":"2024-06-07","current":-0.294563,"twenty":-0.413309,"median":-0.372878,"eighty":-0.310639,"marketCap":56525752},{"date":"2024-06-14","current":-0.291035,"twenty":-0.410081,"median":-0.371179,"eighty":-0.308355,"marketCap":55848797},{"date":"2024-06-21","current":-0.286626,"twenty":-0.409401,"median":-0.368234,"eighty":-0.301829,"marketCap":55002603},{"date":"2024-06-28","current":-0.270751,"twenty":-0.409061,"median":-0.366932,"eighty":-0.301173,"marketCap":51956305},{"date":"2024-07-05","current":-0.264578,"twenty":-0.407601,"median":-0.361535,"eighty":-0.298647,"marketCap":50771634},{"date":"2024-07-12","current":-0.28839,"twenty":-0.40373,"median":-0.353221,"eighty":-0.295445,"marketCap":55341081},{"date":"2024-07-15","current":-0.28839,"twenty":-0.403661,"median":-0.351997,"eighty":-0.295445,"marketCap":55341081},{"date":"2024-08-02","current":-0.30691,"twenty":-0.403593,"median":-0.350774,"eighty":-0.295445,"marketCap":58895095},{"date":"2024-08-09","current":-0.28839,"twenty":-0.402946,"median":-0.34384,"eighty":-0.294206,"marketCap":55341081},{"date":"2024-08-16","current":-0.309698,"twenty":-0.402097,"median":-0.3423,"eighty":-0.293345,"marketCap":53669674},{"date":"2024-08-23","current":-0.322479,"twenty":-0.400738,"median":-0.337815,"eighty":-0.294206,"marketCap":55884613},{"date":"2024-08-30","current":-0.320512,"twenty":-0.399365,"median":-0.334277,"eighty":-0.294563,"marketCap":55543853},{"date":"2024-09-06","current":-0.314613,"twenty":-0.398685,"median":-0.332486,"eighty":-0.294916,"marketCap":54521574},{"date":"2024-09-13","current":-0.309698,"twenty":-0.398359,"median":-0.332045,"eighty":-0.295445,"marketCap":53669674},{"date":"2024-09-20","current":-0.340176,"twenty":-0.398359,"median":-0.331604,"eighty":-0.295445,"marketCap":58951452},{"date":"2024-09-27","current":-0.2979,"twenty":-0.398019,"median":-0.327395,"eighty":-0.295798,"marketCap":51625115},{"date":"2024-10-04","current":-0.314613,"twenty":-0.396762,"median":-0.323462,"eighty":-0.296327,"marketCap":54521574},{"date":"2024-10-11","current":-0.336243,"twenty":-0.395369,"median":-0.327395,"eighty":-0.296327,"marketCap":58269932},{"date":"2024-10-18","current":-0.362789,"twenty":-0.394962,"median":-0.331327,"eighty":-0.296956,"marketCap":62870190},{"date":"2024-10-25","current":-0.343125,"twenty":-0.394282,"median":-0.332398,"eighty":-0.2979,"marketCap":59462592},{"date":"2024-10-31","current":-0.350008,"twenty":-0.393263,"median":-0.332486,"eighty":-0.298033,"marketCap":60655251},{"date":"2024-11-08","current":-0.33231,"twenty":-0.391781,"median":-0.332486,"eighty":-0.298629,"marketCap":57588412},{"date":"2024-11-15","current":-0.387645,"twenty":-0.387286,"median":-0.33396,"eighty":-0.298901,"marketCap":59610428},{"date":"2024-11-22","current":-0.374316,"twenty":-0.385465,"median":-0.33526,"eighty":-0.298973,"marketCap":57560786},{"date":"2024-11-29","current":-0.443181,"twenty":-0.393263,"median":-0.336243,"eighty":-0.298973,"marketCap":68150604},{"date":"2024-12-06","current":-0.455399,"twenty":-0.39564,"median":-0.339193,"eighty":-0.299866,"marketCap":70029443},{"date":"2024-12-13","current":-0.415413,"twenty":-0.398359,"median":-0.339541,"eighty":-0.300736,"marketCap":63880516},{"date":"2024-12-20","current":-0.348769,"twenty":-0.398359,"median":-0.340176,"eighty":-0.301829,"marketCap":53632305},{"date":"2024-12-27","current":-0.353212,"twenty":-0.398359,"median":-0.340176,"eighty":-0.301829,"marketCap":54315519},{"date":"2025-01-03","current":-0.355433,"twenty":-0.398359,"median":-0.34173,"eighty":-0.302962,"marketCap":54657126},{"date":"2025-01-10","current":-0.405416,"twenty":-0.398359,"median":-0.343097,"eighty":-0.304593,"marketCap":62343284},{"date":"2025-01-17","current":-0.409859,"twenty":-0.401077,"median":-0.344248,"eighty":-0.306233,"marketCap":63026498},{"date":"2025-01-24","current":-0.435406,"twenty":-0.40373,"median":-0.345715,"eighty":-0.306728,"marketCap":66954979},{"date":"2025-01-31","current":-0.418745,"twenty":-0.408369,"median":-0.346075,"eighty":-0.30678,"marketCap":64392927},{"date":"2025-02-07","current":-0.492053,"twenty":-0.409859,"median":-0.34988,"eighty":-0.307074,"marketCap":75665959},{"date":"2025-02-14","current":-0.473171,"twenty":-0.413191,"median":-0.351865,"eighty":-0.307731,"marketCap":72762299},{"date":"2025-02-21","current":-0.468728,"twenty":-0.415413,"median":-0.353212,"eighty":-0.307731,"marketCap":72079085},{"date":"2025-02-28","current":-0.406527,"twenty":-0.418745,"median":-0.354323,"eighty":-0.308355,"marketCap":62514088},{"date":"2025-03-07","current":-0.39653,"twenty":-0.416524,"median":-0.35567,"eighty":-0.308355,"marketCap":60976856},{"date":"2025-03-14","current":-0.486438,"twenty":-0.418745,"median":-0.357655,"eighty":-0.308355,"marketCap":62514088},{"date":"2025-03-21","current":-0.518803,"twenty":-0.425409,"median":-0.358364,"eighty":-0.309698,"marketCap":66673486},{"date":"2025-03-28","current":-0.180978,"twenty":-0.428742,"median":-0.357873,"eighty":-0.308355,"marketCap":23258192},{"date":"2025-04-04","current":-0.164891,"twenty":-0.425409,"median":-0.357272,"eighty":-0.30691,"marketCap":21190797},{"date":"2025-04-11","current":-0.133414,"twenty":-0.422992,"median":-0.355433,"eighty":-0.303717,"marketCap":17145595},{"date":"2025-04-17","current":-0.32442,"twenty":-0.42226,"median":-0.354323,"eighty":-0.301829,"marketCap":41692464},{"date":"2025-04-21","current":-0.361956,"twenty":-0.422077,"median":-0.354682,"eighty":-0.301829,"marketCap":46516385}],"updateTime":1745321239875}}}